IESE (España)
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Jose Cuervo: Going Public
Jansat Mayench, Oriol; Carbonell López; Óscar; Rahnema Alavi, AhmadCase F-975-EFinanceThe initial public offering of José Cuervo (JC) in February 2017 marked a milestone in the world of tequila, as the first tequila company in the world to go public. The listing of the Mexican company was especially relevant because it took place months after the arrival of President Donald Trump to the White House. He had criticized the Mexican government and the need to renegotiate the North American Free Trade Agreement (NAFTA). The listing led...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Jose Cuervo: Salida a bolsa
Jansat Mayench, Oriol; Carbonell López; Óscar; Rahnema Alavi, AhmadCase F-975FinanceLa salida a bolsa de Jose Cuervo (JC) en febrero de 2017 marcó todo un hito en el mundo del tequila por el hecho de ser la primera empresa tequilera del mundo en salir a bolsa. La salida de la empresa mexicana fue especialmente relevante porque se produjo meses después de la llegada a la Casa Blanca del presidente Donald Trump, que había criticado al Gobierno mexicano y había planteado la necesidad de renegociar el Tratado de Libre Comercio de Am...Starting at €8.20